Calciphylaxis
Rare and serious disease characterized by calcification of blood vessels
Calciphylaxis | |
---|---|
[[File:|250px|alt=|]] | |
Synonyms | Calcific uremic arteriolopathy |
Pronounce | N/A |
Field | Nephrology, Dermatology |
Symptoms | Painful skin ulcers, necrosis |
Complications | Sepsis, organ failure |
Onset | |
Duration | |
Types | N/A |
Causes | Chronic kidney disease, hyperparathyroidism, diabetes mellitus |
Risks | End-stage renal disease, obesity, female gender |
Diagnosis | Skin biopsy, clinical evaluation |
Differential diagnosis | Warfarin-induced skin necrosis, cholesterol embolism |
Prevention | |
Treatment | Sodium thiosulfate, wound care, pain management |
Medication | |
Prognosis | Poor |
Frequency | Rare |
Deaths |
Calciphylaxis, also known as calcific uremic arteriolopathy, is a rare and serious disease characterized by the calcification of small blood vessels within the dermis and subcutaneous tissue. This condition leads to the development of painful skin ulcers and can result in necrosis.
Symptoms[edit | edit source]
The primary symptoms of calciphylaxis include:
- Painful skin ulcers
- Areas of necrosis
- Erythema and induration around the affected areas
Complications[edit | edit source]
Calciphylaxis can lead to severe complications such as:
Causes[edit | edit source]
The exact cause of calciphylaxis is not fully understood, but it is commonly associated with:
Risk Factors[edit | edit source]
Several risk factors have been identified for calciphylaxis, including:
Diagnosis[edit | edit source]
Diagnosis of calciphylaxis is typically made through:
- Clinical evaluation
- Skin biopsy
Differential Diagnosis[edit | edit source]
Conditions that may present similarly and should be considered include:
Treatment[edit | edit source]
Treatment options for calciphylaxis focus on managing symptoms and may include:
Prognosis[edit | edit source]
The prognosis for calciphylaxis is generally poor, with a high risk of mortality due to complications such as sepsis and organ failure.
See also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD